Figures computed from official regulatory filings — .
Analysttarget 13.25 USD (+103%) · consensus 3/5 · 0 buy · 2 hold · 0 sell
Ownershipinsiders 0.58% · institutions 4.34% · short 10.5% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for AETHLON MEDICAL INC only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
54 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Gikakis Nicolas | Other | $1.8K | SEC |
| Shah Chetan | Other | $1.8K | SEC |
| BROENNIMAN EDWARD G | Other | $894.6 | SEC |
| Rossetti Angela | Award | $50K | Unusual size | SEC |
| Shah Chetan | Award | $50K | SEC |
| BROENNIMAN EDWARD G | Award | $50K | SEC |
| Gikakis Nicolas | Award | $50K | SEC |
| Shah Chetan | Other | $389.8 | SEC |
| Gikakis Nicolas | Other | $389.8 | SEC |
| BROENNIMAN EDWARD G | Other | $194.9 | SEC |
| BROENNIMAN EDWARD G | Other | $246.5 | SEC |
| Shah Chetan | Other | $495.8 | SEC |
| Gikakis Nicolas | Other | $495.8 | SEC |
| Gikakis Nicolas | Other | $1.3K | SEC |
| Shah Chetan | Other | $1.3K | SEC |
| BROENNIMAN EDWARD G | Other | $669.8 | SEC |
| BROENNIMAN EDWARD G | Other | $1.1K | SEC |
| Gikakis Nicolas | Other | $2.1K | SEC |
| Shah Chetan | Other | $2.1K | SEC |
| Gikakis Nicolas | Award | $50K | SEC |
| Shah Chetan | Award | $51.4K | SEC |
| BROENNIMAN EDWARD G | Award | $50K | SEC |
| Rossetti Angela | Award | $50K | Unusual size | SEC |
| BROENNIMAN EDWARD G | Other | $592.2 | SEC |
| Shah Chetan | Other | $1.2K | SEC |